Response assessment in metastatic melanoma treated with ipilimumab and bevacizumab: CT tumor size and density as markers for response and outcome

BACKGROUND: Investigate the tumor diameter and density changes in advanced melanoma patients treated with ipilimumab plus bevacizumab, compare response rates based on different response criteria, and study association between these measures and survival. METHODS: Twenty-one advanced melanoma patient...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Immunother Cancer
Autori principali: Nishino, Mizuki, Giobbie-Hurder, Anita, Ramaiya, Nikhil H, Hodi, F Stephen
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2014
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4236430/
https://ncbi.nlm.nih.gov/pubmed/25411640
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-014-0040-2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi